The combination of JNKi (with either SP600125 or JNK-IN-8) and TRAIL induced a robust reduction in cell viability in all three cancer cell lines tested: Panc1, MiaPaCa2, and L3.6pl (Figure 3B). Here, TNFSF10 is linked to cancer.